Gilead Sciences ( Gilead Sciences )
Management of Gilead Sciences
John C. Martin is the Chairman of the Company. He earned a bachelor's degree in chemical engineering from Purdue University and an MBA in marketing from Golden Gate University and a PhD in organic chemistry from the University of Chicago. John F. Milligan is the CEO of the Company.
Foster City, California, U.S.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Gilead Sciences, Inc., commonly known as Gilead Sciences or Gilead (also styled GILEAD) /ˈɡɪliəd/, is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.